Ho Namkoong

5.9k total citations
137 papers, 1.9k citations indexed

About

Ho Namkoong is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ho Namkoong has authored 137 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Epidemiology, 59 papers in Infectious Diseases and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ho Namkoong's work include Mycobacterium research and diagnosis (53 papers), Tuberculosis Research and Epidemiology (35 papers) and Infectious Diseases and Mycology (18 papers). Ho Namkoong is often cited by papers focused on Mycobacterium research and diagnosis (53 papers), Tuberculosis Research and Epidemiology (35 papers) and Infectious Diseases and Mycology (18 papers). Ho Namkoong collaborates with scholars based in Japan, United States and Sweden. Ho Namkoong's co-authors include Naoki Hasegawa, Makoto Ishii, Tomoko Betsuyaku, Nobuyuki Horita, Takanori Asakura, Sadatomo Tasaka, Kazuma Yagi, Shoji Suzuki, Takahiro Asami and Yohei Funatsu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Ho Namkoong

130 papers receiving 1.9k citations

Peers

Ho Namkoong
Takanori Asakura Japan
Atsuyuki Kurashima Japan
Kyung‐Wook Jo South Korea
Byung Woo Jhun South Korea
Jessica Rademacher Germany
David Prince Australia
Qiang Li China
Gabriele Kropshofer Austria
Jin Woo Song South Korea
Heather Milburn United Kingdom
Takanori Asakura Japan
Ho Namkoong
Citations per year, relative to Ho Namkoong Ho Namkoong (= 1×) peers Takanori Asakura

Countries citing papers authored by Ho Namkoong

Since Specialization
Citations

This map shows the geographic impact of Ho Namkoong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Namkoong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Namkoong more than expected).

Fields of papers citing papers by Ho Namkoong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Namkoong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Namkoong. The network helps show where Ho Namkoong may publish in the future.

Co-authorship network of co-authors of Ho Namkoong

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Namkoong. A scholar is included among the top collaborators of Ho Namkoong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Namkoong. Ho Namkoong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hyejin, Hee Jae Huh, Ho Namkoong, et al.. (2025). Novel Genetic Loci for Nontuberculous Mycobacterial Pulmonary Disease and Potential Protective Effect of Body Mass Index. American Journal of Respiratory and Critical Care Medicine. 211(11). 2191–2202.
2.
Namkoong, Ho, Shuhei Azekawa, Kensuke Nakagawara, et al.. (2023). Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review. Infection and Drug Resistance. Volume 16. 3955–3963. 1 indexed citations
3.
Wang, Qingbo S., Ryuya Edahiro, Ho Namkoong, et al.. (2023). Estimating gene-level false discovery probability improves eQTL statistical fine-mapping precision. NAR Genomics and Bioinformatics. 5(4). lqad090–lqad090.
4.
Morita, Atsuho, Ho Namkoong, Yoshifumi Uwamino, et al.. (2023). Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences. Journal of Infection and Chemotherapy. 30(2). 159–163.
5.
Yoshifuji, Ayumi, Tetsuo Nakayama, Setsuko Mise‐Omata, et al.. (2023). Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis. Vaccines. 11(7). 1214–1214. 3 indexed citations
6.
Chen, Hao, Nobuyuki Horita, Ho Namkoong, et al.. (2022). Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy. Therapeutic Advances in Medical Oncology. 14. 4277477184–4277477184.
7.
Mise‐Omata, Setsuko, Mari Ikeda, Masaru Takeshita, et al.. (2022). Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant. The Journal of Immunology. 209(11). 2104–2113. 14 indexed citations
8.
Takase-Minegishi, Kaoru, Yohei Kirino, Naoki Hamada, et al.. (2022). Benefits and risks of haematopoietic stem cell transplantation for systemic sclerosis: A systematic review and meta-analysis. Modern Rheumatology. 33(2). 330–337. 4 indexed citations
9.
Tanaka, Hiromu, Takanori Asakura, Jun Kikuchi, et al.. (2022). Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept). SHILAP Revista de lepidopterología. 1 indexed citations
10.
Kato, Shingo, Kazuki Fukui, Naoki Nakayama, et al.. (2022). Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis. Heart and Vessels. 37(9). 1570–1582. 6 indexed citations
11.
Minegishi, Shintaro, Sho Kinguchi, Nobuyuki Horita, et al.. (2022). Immune Checkpoint Inhibitors Do Not Increase Short-Term Risk of Hypertension in Cancer Patients: a Systematic Literature Review and Meta-Analysis. Hypertension. 79(11). 2611–2621. 19 indexed citations
12.
Horita, Nobuyuki, Ho Namkoong, Yu Fujiwara, et al.. (2022). Adverse events induced by nivolumab and ipilimumab combination regimens. Therapeutic Advances in Medical Oncology. 14. 4277470425–4277470425. 14 indexed citations
13.
Namkoong, Ho, Koichi Fukunaga, Yuki Enoki, et al.. (2022). Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system. BMC Infectious Diseases. 22(1). 580–580. 4 indexed citations
14.
Takase-Minegishi, Kaoru, Yohei Kirino, Ho Namkoong, et al.. (2021). Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis. Modern Rheumatology. 32(6). 1153–1162. 7 indexed citations
15.
16.
Chen, Hao, Nobuyuki Horita, Ho Namkoong, et al.. (2021). ABO blood group as a risk factor for tuberculosis: A network meta-analysis. International Journal of Infectious Diseases. 104. 701–707. 3 indexed citations
17.
Kamo, Tetsuro, Sadatomo Tasaka, Takeshi Suzuki, et al.. (2019). Prognostic values of the Berlin definition criteria, blood lactate level, and fibroproliferative changes on high-resolution computed tomography in ARDS patients. BMC Pulmonary Medicine. 19(1). 37–37. 26 indexed citations
18.
Namkoong, Ho, Makoto Ishii, Hideki Fujii, et al.. (2019). Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice. Biochemical and Biophysical Research Communications. 513(2). 405–411. 16 indexed citations
19.
Yagi, Kazuma, Makoto Ishii, Ho Namkoong, et al.. (2017). The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases. BMC Infectious Diseases. 17(1). 558–558. 40 indexed citations
20.
Horita, Nobuyuki, Shusaku Haranaga, Ho Namkoong, et al.. (2016). Beta‐lactam plus macrolides or beta‐lactam alone for community‐acquired pneumonia: A systematic review and meta‐analysis. Respirology. 21(7). 1193–1200. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takanori Asakura Breakdown of academic impact, for papers by Atsuyuki Kurashima Breakdown of academic impact, for papers by Kyung‐Wook Jo Breakdown of academic impact, for papers by Byung Woo Jhun Breakdown of academic impact, for papers by Jessica Rademacher Breakdown of academic impact, for papers by David Prince Breakdown of academic impact, for papers by Qiang Li Breakdown of academic impact, for papers by Gabriele Kropshofer Breakdown of academic impact, for papers by Jin Woo Song Breakdown of academic impact, for papers by Heather Milburn
Rankless by CCL
2026